NCT07483060 2026-03-19
NG-ST
Vastra Gotaland Region
Phase 4 Not yet recruiting
Clinical Trials
8 trialsNCT07469306 2026-03-13
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07467330 2026-03-12
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Fujian Cancer Hospital
Phase 3 Recruiting
NCT06787183 2026-03-03
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
Fujian Cancer Hospital
Phase 2 Recruiting
NCT07331428 2026-01-09
MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07185672 2025-09-22
PReCedeNT
Tata Memorial Hospital
Phase 3 Recruiting
NCT06333769 2025-08-15
Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT04864067 2025-07-01
NOAHS-ARC
Servicio de Salud Metropolitano Sur Oriente
Phase 2 Active not recruiting